The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM

Medical Physics

Volumn 39, Issue 3, 2012, Pages 1386-1409

  Allen Li, X ^a   Alber, Markus ^b   Deasy, Joseph O ^c   Jackson, Andrew ^c   Ken Jee, Kyung Wook ^d   Marks, Lawrence B ^e   Martel, Mary K ^f   Mayo, Charles ^g   Moiseenko, Vitali ^h   Nahum, Alan E ⁱ   Niemierko, Andrzej ^d   Semenenko, Vladimir A ^a   Yorke, Ellen D ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g MAYO CLINIC   (United States)

^h Vancouver Cancer Center   (Canada)

ⁱ CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

biologically based treatment planning; EUD; NTCP; outcome modeling; planning system QA; TCP

Indexed keywords

ACCEPTANCE TESTS; QUALITY ASSURANCE;

BIOLOGICALLY BASED MODELS; CLINICAL TREATMENTS; DOSE-RESPONSE MODELS; NTCP; PLANNING SYSTEMS; STEEP LEARNING CURVE; TREATMENT PLANNING; TREATMENT PLANNING SYSTEMS;

QUALITY CONTROL;

EID: 84857870461     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3685447     Document Type: Article

References (74)

1. C. C. Ling and X. A. Li, Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity., Med. Phys. 32, 2189-2192 (2005). 10.1118/1.1930908
2. M. V. Graham, J. A. Purdy, B. Emami, W. Harms, W. Bosch, M. A. Lockett, and C. A. Perez, Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small lung cancer (NSCLC)., Int. J. Radiat. Oncol., Biol., Phys. 45, 323-329 (1999). 10.1016/S0360-3016(99)00183-2
3. L. B. Marks, S. M. Bentzen, J. O. Deasy, F. M. Kong, J. D. Bradley, I. S. Vogelius, I. El Naqa, J. L. Hubbs, J. V. Lebesque, R. D. Timmerman, M. K. Martel, and A. Jackson, Radiation dose-volume effects in the lung., Int. J. Radiat. Oncol., Biol., Phys. 76 (3 Suppl), S70-S76 (2010). 10.1016/j.ijrobp. 2009.06.091
4. J. O. Deasy, Multiple local minima in radiotherapy optimization problems with dose-volume constraints., Med. Phys. 24, 1157-1161 (1997). 10.1118/1.598017
5. Q. Wu and R. Mohan, Multiple local minima in IMRT optimization based on dose-volume criteria., Med. Phys. 29, 1514-1527 (2002). 10.1118/1.1485059
6. R. D. Stewart and X. A. Li, BGRT: Biologically guided radiation therapy-The future is fast approaching, Med. Phys. 34, 3739-3751 (2007). 10.1118/1.2779861
7. A. Brahme, Optimized radiation therapy based on radiobiological objectives., Semin. Radiat. Oncol. 9, 35-47 (1999). 10.1016/S1053-4296(99)80053- 8
8. C. C. Ling, J. Humm, S. Larson, H. Amols, Z. Fuks, S. Leibel, and J. A. Koutcher, Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality., Int. J. Radiat. Oncol., Biol., Phys. 47, 551-560 (2000). 10.1016/S0360-3016(00)00467-3
9. Y. Yang and L. Xing, Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution., Med. Phys. 32, 1473-1484 (2005). 10.1118/1.1924312
10. S. M. Bentzen, Theragnostic imaging for radiation oncology: Dose-painting by numbers., Lancet Oncol. 6, 112-117 (2005). 10.1016/S1470-2045(05)01737-7
11. Y. Kim and W. A. Tomé, Risk-Adaptive Optimization: Selective Boosting of high-risk tumor subvolumes., Int J. Radiat. Oncol., Biol., Phys. 66, 1528-42 (2006). 10.1016/j.ijrobp.2006.08.032
12. A. Svik, E. Malinen, H. K. Skogmo, S. M. Bentzen, O. S. Bruland, and D. R. Olsen, Radiotherapy adapted to spatial and temporal variability in tumor hypoxia., Int. J. Radiat. Oncol., Biol., Phys. 68, 1496-1504 (2007). 10.1016/j.ijrobp.2007.04.027
13. www.AAPM.org
14. A. Niemierko, Reporting and analyzing dose distributions: A concept of equivalent uniform dose., Med. Phys. 24, 103-110 (1997). 10.1118/1.598063
15. A. Niemierko, A generalized concept of equivalent uniform dose (EUD)., Med. Phys. 26, 1101 (1999).
16. B. Choi and J. O. Deasy, The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning., Phys. Med. Biol. 47, 3579-3589 (2002). 10.1088/0031-9155/47/20/302
17. H. E. Romeijn, J. F. Dempsey, and J. G. Li, A unifying framework for multi-criteria fluence map optimization models., Phys. Med. Biol. 49, 1991-2013 (2004). 10.1088/0031-9155/49/10/011
18. M. Alber and R. Reemtsen, Intensity modulated radiation therapy planning by use of a barrier-penalty multiplier method., Optimization, Methods and Software (OMS) (Taylor Francis, London, 2007), Vol. 22, pp. 391-411.
19. Q. Wu, D. Djajaputra, Y. Wu, J. Zhou, H. H. Liu, and R. Mohan, Intensity-modulated radiotherapy optimization with gEUD-guided dose-volume objectives., Phys. Med. Biol. 48, 279-291 (2003). 10.1088/0031-9155/48/3/301
20. D. N. Mihailidis, B. Plants, L. Farinash, M. Harmon, L. Whaley, P. Paja, and P. Tomara, Superiority of equivalent uniform dose (EUD)-based optimization for breast and chest wall., Med. Dosim. 35, 67-76 (2010) 10.1016/j.meddos.2009. 03.002
21. P. Källman, B. K. Lind, and A. Brahme, An algorithm for maximizing the probability of complication-free tumour control in radiation therapy., Phys. Med. Biol. 37, 871-890 (1992). 10.1088/0031-9155/37/4/004
22. Q. Wu, R. Mohan, A. Niemierko, and R. Schmidt-Ullrich, Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose., Int. J. Radiat. Oncol., Biol., Phys. 52, 224-235 (2002). 10.1016/S0360-3016(01) 02585-8
23. W. R. De Gersem, S. Derycke, C. O. Colle, C. De Wagter, and W. J. De Neve, Inhomogeneous target-dose distributions: A dimension more for optimization?, Int. J. Radiat. Oncol., Biol., Phys. 44, 461-468 (1999). 10.1016/S0360-3016(98)00464-7
24. QUANTEC, Int. J. Radiat. Oncol. Biol. Phys. 76 (3 Suppl) (2010).
25. S. H. Benedict, K. M. Yenice, D. Followill, J. M. Galvin, W. Hinson, B. Kavanagh, P. Keall, M. Lovelock, S. Meeks, L. Papiez, T. Purdie, R. Sadagopan, M. C. Schell, B. Salter, D. J. Schlesinger, A. S. Shiu, T. Solberg, D. Y. Song, V. Stieber, R. Timmerman, W. A. Tomé, D. Verellen, L. Wang, and F. F. Yin, Stereotactic body radiation therapy: The report of AAPM Task Group 101., Med Phys. 37, 4078-4101 (2010). 10.1118/1.3438081
26. I. Kawrakow, The effect of Monte Carlo statistical uncertainties on the evaluation of dose distributions in radiation treatment planning., Phys. Med. Biol. 49, 1549-1556 (2004). 10.1088/0031-9155/49/8/012
27. R. K. Ten Haken, T. S. Lawrence, and L. A. Dawson, Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: In regards to Xu (Int J Radiat Oncol Biol Phys 2006;65:189-195)., Int. J. Radiat. Oncol., Biol., Phys. 66, 1272 (2006). 10.1016/j.ijrobp.2006.08. 003
28. E. S. Koh, A. Sun, T. H. Tran, R. Tsang, M. Pintilie, D. C. Hodgson, W. Wells, R. Heaton, and M. K. Gospodarowicz, Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma., Int. J. Radiat. Oncol., Biol., Phys. 66, 223-228 (2006). 10.1016/j.ijrobp.2006.03.063
29. J. T. Lyman, Complication probability as assessed from dose-volume histograms., Radiat. Res. Suppl. 8, S13-S19 (1985). 10.2307/3583506
30. G. J. Kutcher and C. Burman, Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method., Int. J. Radiat. Oncol., Biol., Phys. 16, 1623-1630 (1989). 10.1016/0360- 3016(89)90972-3
31. L. A. Dawson, D. Normolle, J. M. Balter, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, Analysis of radiation-induced liver disease using the Lyman NTCP model., Int. J. Radiat. Oncol., Biol., Phys. 53, 810-821 (2002). Erratum in
32. L. A. Dawson, D. Normolle, J. M. Balter, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, Int. J. Radiat. Oncol., Biol., Phys. 53, 1422 (2002). 10.1016/S0360-3016(02)02846-8
33. Y. Seppenwoolde, J. V. Lebesque, K. de Jaeger, J. S. Belderbos, L. J. Boersma, C. Schilstra, G. T. Henning, J. A. Hayman, M. K. Martel, and R. K. Ten Haken, Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability., Int. J. Radiat. Oncol., Biol., Phys. 55, 724-735 (2003). 10.1016/S0360-3016(02)03986-X
34. Z. Y. Xu, S. X. Liang, J. Zhu, X. D. Zhu, J. D. Zhao, H. J. Lu, Y. L. Yang, L. Chen, A. Y. Wang, X. L. Fu, and G. L. Jiang, Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma., Int. J. Radiat. Oncol., Biol., Phys. 65, 189-195 (2006). 10.1016/j.ijrobp.2005.11.034
35. M. Zaider and H. I. Amols, A little to a lot or a lot to a little: Is NTCP always minimized in multiport therapy?, Int. J. Radiat. Oncol., Biol., Phys. 41, 945-950 (1998). 10.1016/S0360-3016(98)00128-X
36. V. Moiseenko, J. Battista, and J. Van Dyk, Normal tissue complication probabilities: Dependence on choice of biological model and dose-volume histogram reduction scheme., Int. J. Radiat. Oncol., Biol., Phys. 46, 983-993 (2000). 10.1016/S0360-3016(99)00473-3
37. L. P. Muren, N. Jebsen, A. Gustafsson, and O. Dahl, Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters., Int. J. Radiat. Oncol., Biol., Phys. 50, 627-637 (2001). 10.1016/S0360-3016(01)01464-X
38. B. Sanchez-Nieto and A. E. Nahum, The delta-TCP concept: A clinically useful measure of tumor control probability., Int. J. Radiat. Oncol., Biol., Phys. 44, 369-380 (1999). 10.1016/S0360-3016(99)00029-2
39. W. A. Tomé and J. F. Fowler, Selective boosting of tumor subvolumes., Int. J. Radiat. Oncol., Biol., Phys. 48, 593-599 (2000). 10.1016/S0360-3016(00)00666-0
40. W. A. Tomé and J. F. Fowler, On cold spots in tumor subvolumes., Med. Phys. 29, 1590-1598 (2002). 10.1118/1.1485060
41. P. Okunieff, D. Morgan, A. Niemierko, and H. D. Suit, Radiation dose-response of human tumors., Int. J. Radiat. Oncol., Biol., Phys. 32, 1227-1237 (1995). 10.1016/0360-3016(94)00475-Z
42. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, Tolerance of normal tissue to therapeutic irradiation., Int. J. Radiat. Oncol., Biol., Phys. 21, 109-122 (1991). 10.1016/0360-3016(91)90171-Y
43. V. A. Semenenko, B. Reitz, E. Day, X. S. Qi, M. Miften, and X. A. Li, Evaluation of a commercial biologically based IMRT treatment planning system., Med. Phys. 35, 5851-5860 (2008). 10.1118/1.3013556
44. X. S. Qi, V. A. Semenenko, X. A. Li, Improved critical structure sparing with biologically-based IMRT optimization., Med. Phys. 36, 1790-1799 (2009). 10.1118/1.3116775
45. G. J. Kutcher, L. Coia, M. Gillin, W. F. Hanson, S. Leibel, R. J. Morton, J. R. Palta, J. A. Purdy, L. E. Reinstein, G. K. Svensson, M. Weller, and L. Wingfield, Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40., Med. Phys. 21, 581-618 (1994). 10.1118/1.597316
46. B. Fraass, K. Doppke, M. Hunt, G. Kutcher, G. Starkschall, R. Stern, and J. Van Dyke, American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning., Med. Phys. 25, 1773-1829 (1998). 10.1118/1.598373
47. G. A. Ezzell, J. W. Burmeister, N. Dogan, T. J. Losasso, J. G. Mechalakos, D. Mihailidis, A. Molineu, J. R. Palta, C. R. Ramsey, B. J. Salter, J. Shi, P. Xia, N. J. Yue, and Y. Xiao, IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119., Med. Phys. 36, 5359-5373 (2009). 10.1118/1.3238104
48. E. E. Klein, J. Hanley, J. Bayouth, F. F. Yin, W. Simon, S. Dresser, C. Serago, F. Aguirre, L. Ma, B. Arjomandy, C. Liu, C. Sandin, and T. Holmes, Task Group 142 report: Quality assurance of medical accelerators., Med Phys. 36, 4197-212 (2009). 10.1118/1.3190392
49. J. O. Deasy, A. I. Blanco, and V. H. Clark, CERR: A computational environment for radiotherapy research., Med. Phys. 30, 979-985 (2003). 10.1118/1.1568978
50. http://radium.wustl.edu/CERR/about.php
51. B. Sanchez-Nieto and A. E. Nahum, BIOPLAN: Software for the biological evaluation of radiotherapy treatment plans., Med. Dosim. 25, 71-76 (2000). 10.1016/S0958-3947(00)00031-5
52. J. Uzan and A. E. Nahum, BioSuite, new software for radiobiological customisation of dose and fraction size in external-beam radiothearapy, 10th Biennial ESTRO meeting (2009).
53. http://www.aapm.org/org/committees/TG166/TG166prostate.zip.
54. http://www.aapm.org/org/committees/TG166/TG166headneck.zip.
55. http://www.aapm.org/org/committees/TG166/TG166brain.zip.
56. http://www.aapm.org/org/committees/TG166/EUD-Monaco-Pinnacle-Eclipse.xls.
57. ICRU, Prescribing, recording and reporting photon beam therapy, ICRU Report No. 50 (International Commission on Radiation Units and Measurements, Washington, DC, 1993).
58. J. H. Killoran, H. M. Kooy, D. J. Gladstone, F. J. Welte, and C. J. Beard, A numerical simulation of organ motion and daily setup uncertainties: Implications for radiation therapy., Int. J. Radiat. Oncol., Biol., Phys. 37, 213-221 (1997). 10.1016/S0360-3016(96)00477-4
59. D. J. Brenner and R. K. Sachs, A more robust biologically based ranking criterion for treatment plans., Int. J. Radiat. Oncol., Biol., Phys. 43, 697-698 (1999). 10.1016/S0360-3016(98)00438-6
60. S. Das, A role for biological optimization within the current treatment planning paradigm., Med Phys. 36, 4672-4682 (2010). 10.1118/1.3220211
61. Y. Lu, D. R. Spelbring, and G. T. Chen, Functional dose-volume histograms for functionally heterogeneous normal organs., Phys. Med. Biol. 42, 345-56 (1997). 10.1088/0031-9155/42/2/007
62. L. B. Marks, G. W. Sherouse, M. T. Munley, G. C. Bentel, and D. P. Spencer, Incorporation of functional status into dose-volume analysis., Med. Phys. 26, 196-9 (1999). 10.1118/1.598503
63. http://ctep.cancer.gov
64. J. D. Cox, J. Stetz, and T. F. Pajak, Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)., Int. J. Radiat. Oncol., Biol., Phys. 31, 1341-1346 (1995). 10.1016/0360-3016(95)00060-C
65. H. R. Withers, J. M. Taylor, and B. Maciejewski, Treatment volume and tissue tolerance., Int. J. Radiat. Oncol., Biol., Phys. 14, 751-759 (1988). 10.1016/0360-3016(88)90098-3
66. M. Alber and F. Nüsslin, An objective function for radiation treatment optimization based on local biological measures., Phys. Med. Biol. 44, 479-493 (1999). 10.1088/0031-9155/44/2/014
67. M. Alber, A concept for the optimization of radiotherapy., Ph.D. dissertation, University of Tübingen, Tübingen, Germany, 2000.
68. M. Alber and C. Belka, A normal tissue dose response model of dynamic repair processes., Phys. Med. Biol. 51, 153-172 (2006). 10.1088/0031-9155/51/1/ 012
69. M. Alber, M. Birkner, and F. Nüsslin, Tools for the analysis of dose optimization: II. Sensitivity analysis., Phys. Med. Biol. 47, N265-N270 (2002). 10.1088/0031-9155/47/19/402
70. 3IMRT Biological optimization and EUD, Pinnacle3 White Paper, available at www.medical.philips.com/main/products/ros/assets/docs/white-papers/ EUD-Final.pdf.
71. C. Burman, G. J. Kutcher, B. Emami, and M. Goitein, Fitting of normal tissue tolerance data to an analytic function., Int. J. Radiat. Oncol., Biol., Phys. 21, 123-135 (1991). 10.1016/0360-3016(91)90172-Z
72. B. K. Lind, P. Mavroidis, S. Hyödynmaa, and C. Kappas, Optimization of the dose level for a given treatment plan to maximize the complication-free tumor cure., Acta Oncol. 38, 787-798 (1999). 10.1080/028418699432950
73. G. Kver, B. K. Lind, J. Löf, A. Liander, and A. Brahme, Stochastic optimization of intensity modulated radiotherapy to account for uncertainties in patient sensitivity., Phys. Med. Biol. 44, 2955-2969 (1999). 10.1088/0031-9155/44/12/308
74. P. Källman, A. gren, and A. Brahme, Tumour and normal tissue responses to fractionated non-uniform dose delivery., Int. J. Radiat. Biol. 62, 249-262 (1992). 10.1080/09553009214552071